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Background: Patients in sub-Saharan Africa commonly experience pain, which often is un-assessed and
undertreated. One hindrance to routine pain assessment in these settings is the lack of a single-item pain rating
scale validated for the particular context. The goal of this study was to examine the face validity and cultural
acceptability of two single-item pain scales, the Numerical Rating Scale (NRS) and the Faces Pain Scale-Revised
(FPS-R), in a population of patients on the medical, surgical, and pediatric wards of Moi Teaching and Referral
Hospital in Kenya.
Methods: Swahili versions of the NRS and FPS-R were developed by standard translation and back-translation.
Cognitive interviews were performed with 15 patients at Moi Teaching and Referral Hospital in Eldoret, Kenya.
Interview transcripts were analyzed on a question-by-question basis to identify major themes revealed through the
cognitive interviewing process and to uncover any significant problems participants encountered with
understanding and using the pain scales.
Results: Cognitive interview analysis demonstrated that participants had good comprehension of both the NRS
and the FPS-R and showed rational decision-making processes in choosing their responses. Participants felt that
both scales were easy to use. The FPS-R was preferred almost unanimously to the NRS.
Conclusions: The face validity and acceptability of the Swahili versions of the NRS and FPS-R has been
demonstrated for use in Kenyan patients. The broader application of these scales should be evaluated and may
benefit patients who currently suffer from pain.Background
Sub-Saharan Africa bears a disproportionate measure of the
global burden of many diseases, as well as their attendant
morbidities, including pain [1]. The prevalence of pain is
amplified by lack of access to health facilities, late presenta-
tion, inadequate diagnosis, treatment unavailability, lack of
medical education regarding pain control, and scarcity and
underprescribing of opioids [1-4].
Pain in sub-Saharan Africa has been studied primarily
in three patient populations: HIV/AIDS patients, cancer* Correspondence: ggramels@iupui.edu
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medium, provided the original work is properpatients, and palliative care patients. The prevalence of
pain in African patients with HIV ranges from 59 to
98%, depending on disease stage, similar to the pain
prevalence found in other HIV patient populations [5-8].
Cancer, increasingly prevalent in sub-Saharan Africa with
rates of cancer expected to quadruple over the next
50 years, is also frequently associated with pain [9,10].
One study conducted in Uganda and South Africa found
the prevalence of pain was 87.5% in cancer patients
attending palliative care services [11]. Patients at the
ends of their lives are particularly vulnerable to pain. A
study of hospice patients in Uganda found that two-
thirds had experienced severe, prolonged pain before
having their pain adequately treated [1]. In Kenya,
researchers have found that patients at the ends of their
lives often die in pain [12,13].td. This is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
ly cited.
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whether patients are experiencing pain, manage the pain
appropriately, and then reassess whether efforts to relieve
the pain have been successful. Single-item, continuous
rating scales, commonly used to assess pain, are a valu-
able tool for clinicians to ascertain pain in patients
[14,15]. These include the visual analog scale (VAS), the
graphic rating scale (GRS), the numerical rating scale
(NRS), and the verbal rating scale (VRS). Studies compar-
ing these scales have found similar accuracy and validity
among scales, though the Numerical Rating Scale (NRS)
(Figure 1) has been found to have the highest sensitivity
combined with simplicity of administration [16-22]. A
similar scale, the Faces Pain Scale, developed for use in
pediatric populations, but now validated in all age ranges,
may be particularly helpful in patients who are illiterate
or have language difficulties [23-27]. The Faces Pain
Scale-Revised (FPS-R) (Figure 2) can be scored along the
same 0 to 10 metric as the NRS, and has been shown to
have the best psychometric properties in school-aged
children (4 to 12 years) compared to several other faces
scales, including the Oucher photographic scale and the
Wong-Baker Faces Pain Scale, as well as the Pieces of
Hurt Tool and the VAS [24,28,29].
No single-item pain measurement tool, including the
FPS-R and the NRS, has been validated for use in East
Africa. This is significant as not all pain measurement
tools maintain their reliability when translated into an-
other language or used in another culture [14]. In sub-
Saharan Africa, there have been a limited number of
studies examining the cross-cultural validity of pain as-
sessment tools. The VAS and VRS were administered to
a cohort of 100 Nigerian patients, and both scales were
found to have high levels of correlation [30]. A study of
a six-graded faces pain scale in children ages 4–12 in
South Africa compared the scale to a designated nurse’s
assessment of the child’s pain. This study found a
strong correlation between the two methods and con-
firmed the validity of using a faces pain scale in this
population [31]. Another study undertaken in Nigeria
found that the VAS, NRS, and Oucher photographic
faces pain scales demonstrated high convergent validity
in Nigerian children [32]. Correlation and convergent
validity are important components of validating a scale
for cross-cultural use, but these measures may not ex-
press how well concepts are understood or questions
are accepted in a particular context. Promisingly, a pilotNo
pain
Figure 1 Numerical Rating Scale. Instructions for patients: “If 0 means ‘no
scale from 0 to 10, what is your current level of pain?”acceptability study of the FPS-R showed that 20 adult
Ugandan hospice patients were easily able to choose a
response to the scale, but did not further describe the
participants’ understanding of the scale [33].
There is a pressing need for cross-cultural validation of
functional and appropriate pain assessment tools for use
in East Africa. Recently, particular attention has been
paid to Kenya regarding its failure to provide satisfactory
pain assessment and control in children [34]. Clinicians
in Kenya are not trained to assess pain, pain assessment
is not frequently performed in hospitals, and pain is
often undertreated due to fear of opioids and lack of
prioritization of pain relief [34]. Assessing pain accurately
and in a culturally acceptable manner are crucial first steps
to combating these pain management challenges, both for
pediatric and adult patients. In this study, we chose to
examine the face validity and cross-cultural acceptability
of the NRS and the FPS-R in adult and pediatric Kenyan
patients.
Methods
Setting
This study was performed at Moi Teaching and Referral
Hospital (MTRH) in Eldoret, Kenya. MTRH is a national
referral hospital with a catchment area of Nyanza Province,
North Rift Valley Province, and Western Province, which
have a joint population of about 11.24 million people. The
hospital currently accommodates 500 inpatient beds and a
large outpatient department. Over the past six years,
MTRH has been building an oncology program and re-
cently established palliative care under the auspices of the
oncology department.
This study was approved by the Institutional Re-
search and Ethics Committee of Moi University School
of Medicine and by the Institutional Review Board of
Indiana University.
Development of the Swahili versions of FPS-R and NRS
English and Swahili are the two national languages of
Kenya. An experienced translator skilled in both Swahili
and English translated the FPS-R and NRS into Swahili.
The scales were independently back-translated into English
by bilingual study staff without prior exposure to the ori-
ginal English-language versions. This process of translation
and back-translation was repeated until the scales were con-
sistent in both languages (Figure 3 and Figure 4). The trans-
lations were reviewed for accuracy by a bilingualWorst
imaginable
pain
pain,’ and 10 means ‘the worst pain that you can imagine,’ on this
Figure 2 Faces Pain Scale-Revised. Instructions for patients: “These faces show how much something can hurt. The face on the left shows no
pain. The faces show more and more pain proceeding from left to right, up to the face on the right – it shows the most pain. Point to the face
that shows how much you hurt right now.” Scored 0-2-4-6-8-10. This figure has been reproduced with permission of the International Association
for the Study of Pain® (IASP®). The figure may not be reproduced for any other purpose without permission.
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terms over which there were disagreement; however, no
such conflicts arose.
Population
Using an online random number generator corresponding
to inpatient bed numbers, we randomly selected five adult
medical, five adult surgical, and five pediatric inpatients at
MTRH. These patient populations were chosen to ensure
inclusion of a broad range of disease states and age ranges.
Furthermore, the medical, surgical, and pediatric wards
are the largest and most representative wards at MTRH,
and were prioritized for inclusion in this study by our mul-
tispecialty team of pediatricians, internists, oncologists,
and surgeons. We included patients ages 8 years and over,
with the ability to speak English or Swahili, and with the
mental and physical capacity to give informed assent or
consent and respond to the question probes. Verbal
informed consent and/or assent were obtained from all
participants. We recruited patients until thematic satur-
ation was reached at 15 interviews, which corresponds to
the literature that states performing 12–15 cognitive inter-
views is usually sufficient to maximize the yield of useful
information [35].
Cognitive interviewing and data collection
The two pain scales were administered to each participant.
Subsequently, cognitive interviewing, a qualitative research
method, was used to examine how participants understand,
process, and respond to the pain scales [35]. Cognitive
interviewing has become a key technique in uncovering po-
tential problems with survey questionnaires through aFigure 3 Faces Pain Scale-Revised – Swahili. Instructions for patients: “H
hauonyeshi uchungu. Nyuso hizo zaonyesha uchungu zaidi na zaidi kuanzia
mwingi zaidi. Lenga uso unaoonyesha jinsi unavyoumia sasa hivi.” This figu
Association for the Study of Pain® (IASP®). The figure may not be reproduceprocess of administering draft survey questions and then
probing how subjects comprehend, recall, decide, and re-
spond to the questions [36]. Use of cognitive interviewing
in the pediatric population has been well-documented and
has proven to be a valuable tool for elucidating concerns
specific to children [37-39].
Four trained cognitive interviewers performed the
interviews and were assisted at all times by the first au-
thor to ensure consistency. Standardized, concurrent,
proactive question probes were used as documented in
Additional file 1: Appendix. A combination of compre-
hension/interpretation probes (e.g. “In this question,
what does the word ‘pain’ mean to you?” and “Which
face would you choose if you were not experiencing any
pain?”), as well as general probes (e.g. “How did you de-
cide your answer to this question?”) were employed.
Eight participants were shown the FPS-R first, along
with its corresponding cognitive interview questions,
while seven participants were shown the NRS first, so
as to lessen the effect of order on preference.
Demographic and clinical data were also gathered for
each patient from chart review. These data included age,
date of hospital admission, working diagnosis, chronic
medical problems, and any pain medications received.
Data analysis
The interviews were audiotaped and transcribed. Each tran-
script was then summarized on a question-by-question
basis. Results across the interviews were compiled to create
an organized testing report for each cognitive interviewing
probe that included the major themes elicited by the probe
and the number of respondents whose answers touched onizi nyuso zaonyesha jinsi kitu kinaweza umiza. Uso ulio kushoto
kushoto kuelekea kulia hadi uso ulio kulia – inaonyesha uchungu ulio
re has been reproduced with permission of the International
d for any other purpose without permission.
Hakuna
uchungu
Uchungu
mwingi
unaofikiriwa
Figure 4 Numerical Rating Scale – Swahili. Instructions for patients: “Ikiwa 0 inamaanisha ‘hakuna uchungu,’ na 10 inamaanisha ‘uchungu
mbaya zaidi wenye unaweza kufikiria,’ katika mizani hii ya 0 mpaka 10, ni kipi kiwango chako cha sasa cha uchungu?”
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also highlighted in the testing report. The testing report was
analyzed independently by three investigators to seek out
problems encountered repeatedly across interviews and
whether reported problems could reasonably be attributed
to the characteristics of the pain tools themselves [34]. Any
discrepancies were discussed by the investigators until
agreement was reached. The conclusions of this analysis
were then applied to the FPS-R and NRS to determine if
any changes needed to be made based on the results of the
cognitive interviewing process.Results
Participant characteristics
Fifteen interviews were performed, including seven
women and nine men, with an age range of 8 to 69 years.
One subject was excluded from analysis because his diag-
nosis of acute psychosis rendered him unable to ad-
equately answer questions. Table 1 describes the
participant characteristics, including admission diagnosis.
Responses to the cognitive interviewing probes were easily
elicited and participants did not demonstrate or express
any difficulty in answering them.Table 1 Summary of subjects
Subject Age (years) Gender Service
1 11 Male Pediatrics
2 8 Male Pediatrics
3* 10 Male Pediatrics
4 58 Female Surgery
5 34 Female Surgery
6 43 Male Medicine
7 35 Male Medicine
8 9 Male Pediatrics
9 9 Male Pediatrics
10 30 Female Surgery
11 27 Female Surgery
12 69 Male Medicine
13 12 Female Pediatrics
14 43 Female Medicine
15 36 Female Medicine
16 48 Male Surgery
*Subject 3 was excluded from analysis due to his diagnosis of acute psychosis.Faces pain scale-revised (FPS-R)
The responses to the FPS-R ranged widely, from the first
face (no pain) to the last face (the worst pain of your life)
(Figure 5).Preference
The FPS-R was virtually universally preferred to the Nu-
merical Rating Scale, as 14 of 15 participants favored the
FPS-R, and the remaining participant stated that he liked
both scales. Participants found that the faces were easy to
understand as they visibly depicted pain and the absence of
pain. They felt that the illustrated expressions made it easier
to choose a response to the pain scale, and that the faces
make it easier for medical personnel to understand the pain
that a patient is in: “[Using the faces pain scale] would help
because when the doctor or nurse sees the expression on
the face, they will know the pain I’m feeling. The faces are
easier for both the patient and the doctor” (Subject 5;
35 year-old woman with breast cancer).Decision-making process
Twelve out of 14 participants thought that it was easy to
choose a response on the FPS-R, while one was unsureDiagnosis
Heart failure in rheumatic heart disease
Pulmonary tuberculosis
Acute psychosis
Mesenteric tumor
Breast cancer
Cryptococcal meningitis
Unspecified connective tissue disease
Gastritis or peptic ulcer disease
Nephrotic syndrome
Paraplegia and spinal cord injury from motor vehicle accident
Necrotizing fasciitis
Liver mass with obstructive jaundice
Congestive heart failure in rheumatic heart disease
Peptic ulcer disease
Chronic idiopathic thrombocytopenic purpura
Esophageal cancer
Figure 5 FPS-R Responses. The y-axis depicts the number of participants who chose each face to represent their pain.
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any pain. The reasoning process the participants used
included comparing their current pain to prior levels of
pain during the same hospitalization: “Yesterday, they
did a lumbar puncture – before that procedure, it was
very painful, but today it’s not as bad” (Subject 6;
43 year-old man with cryptococcal meningitis). They also
compared the facial expressions to their own perceived
pain level: “My pain doesn’t reach to face four, just to
face three” (Subject 14; 43 year-old woman with peptic
ulcer disease). “I chose the first one because according to
me, I don’t have pain, but the other faces show pain”
(Subject 15; 36 year-old woman with chronic idiopathic
thrombocytopenic purpura). “The others don’t have a lot
of pain, but I chose the sixth face because I have a lot of
pain” (Subject 13; 12 year-old girl with congestive heart
failure in rheumatic heart disease). Eleven of 12 partici-
pants thought that facial expressions are a fair reflection
of pain (one participant was unsure).Comprehension
The participants were able to accurately describe what the
progression of faces meant on the scale: “The first one
shows no pain, the second shows a little pain, the third
shows more pain, the fourth is much pain, the fifth is a lot
a lot of pain, the sixth is very very painful” (Subject 5).
Fourteen out of 15 participants were able to correctly
identify the first face as the face they would choose if they
were not experiencing any pain, with one participantchoosing the second face. All 15 participants correctly
identified the last face as the face they would choose if they
were experiencing the worst pain of their lives.
Ease of use
Ten out of 14 participants felt that nothing needed to be
changed to make the scale easier to understand. One boy
suggested putting ears on the faces (Subject 1, 11 year-
old boy with congestive heart failure in rheumatic heart
disease). Two men stated that the wrinkles on the faces
help show pain. One woman stated that we should “give
[the faces] medicine to make them feel better” (Subject
11; 27 year-old woman with necrotizing fasciitis). Ten
out of 10 participants felt that there was nothing confus-
ing about the FPS-R.
The cognitive interviewing process supported that the
FPS-R is acceptable to patients as a mechanism for
assessing pain and represents their pain appropriately.
Numerical rating scale (NRS)
There were a wide variety of responses to the NRS, ranging
from zero to 10 (Figure 6). While the FPS-R was preferred
to the NRS, participants generally felt that the NRS would
still be helpful in explaining their pain to their health care
providers.
Decision-making process
Eleven of 14 participants thought that it was easy to ar-
rive at an answer, while one was unsure. Two
Figure 6 Numerical Rating Scale Responses. The y-axis represents the number of participants who chose each number to represent their pain.
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to think first” (Subject 15), and one because “you have to
understand yourself and the progress of your pain before
you can answer according to the scale” (Subject 10;
30 year-old woman with paraplegia and spinal cord injury
from a motor vehicle accident). Similar to the reasoning
process that some participants employed in choosing a re-
sponse to the FPS-R, some patients chose their response
to the NRS by comparing their current pain to prior pain
during the hospitalization: “It’s not like yesterday, today is
better” (Subject 6). “My pain is improving; it is not as bad
as when I came in” (Subject 14).Comprehension
The participants were able to accurately describe what the
progression of the numbers from 0 to 10 meant: “Zero
shows no pain, then as it goes up, it keeps showing a little
pain, then a little bit more, then at the end it shows a lot
of pain, and ten shows the most pain” (Subject 9; 9 year-
old boy with nephrotic syndrome). Eleven of 15 partici-
pants correctly identified zero as the number they would
choose if they were not experiencing any pain. Three parti-
cipants incorrectly chose 1. One participant was confused
by the question and did not answer. Fourteen of 15 partici-
pants correctly identified 10 as the number they would
choose if they were in the worst pain of their lives, while
one switched his answer from 1 to 10.Ease of use
Thirteen of 14 participants felt that the scale was easy
to understand with no changes needed, while one
pointed out that the understandability of the scale
depends on how the scale is explained to the patient.
Seven out of nine participants thought there wasnothing confusing about the scale. One said, “[The
scale] only shows pain” (Subject 7; 35 year-old man
with connective tissue disease), while another asked,
“Does it mean the pain only reaches 10, or can it be
above 10?” (Subject 10).
The cognitive interviewing process supported that the
NRS is also acceptable to patients as a mechanism for
assessing pain and represents their pain appropriately.Discussion
This study demonstrated the face validity and accept-
ability of the Swahili versions of the FPS-R and the
NRS as single-item pain assessment tools for use in
hospitalized Kenyan patients. Of the unidimensional
pain assessment tools available, these scales were
judged by our team to be most practical for use in our
setting in western Kenya, and they also correspond to
the Kenyan Hospice and Palliative Care Association’s
recommendation of using a numerical scale and a faces
scale for pain assessment. These tested translations use
straightforward, non-idiomatic Swahili phrasing, which
should make them usable in other Swahili-speaking
countries of East Africa, as well as in immigrant popu-
lations worldwide.
By using comparisons of their current pain to their previ-
ous levels of pain as well as to the facial expressions of the
FPS-R to select an answer, participants demonstrated ra-
tional decision-making processes in choosing responses to
the FPS-R and the NRS. They showed good comprehension
of the progression from the left-most anchor of no pain to
the right-most anchor of the worst pain on both scales. Par-
ticipants also found the scales easy to use and denied any
confusion with the phrasing of instructions or the scales
themselves. This comprehension and acceptability to
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tures, especially in a setting where pain assessment is not
routinely done.
There were a few suggestions for changes that could
be made to the scales, though none of these were judged
to qualify for revision, as they were determined to be
subjective preferences (one boy wanted to put ears on
the faces) or misunderstandings of the cognitive interview
probes (one woman wanted to give the faces medicine to
make them feel better). The outcomes of cognitive inter-
viewing help define “tradeoffs” – the advantages and disad-
vantages of asking a question in a certain manner – rather
than dictating a “correct” way to ask a question [35]. In
our case, the data generated from cognitive interviewing
demonstrated the advantages of keeping the questions as
they stand rather than making any changes.
Our team had been worried that the FPS-R would not
be understood by Kenyan patients because they might be
unfamiliar with “cartoon” faces. There was also a con-
cern that, in this cultural context, patients would be too
stoic or too afraid of being considered “weak” to admit
to feeling pain. Given the wide range of pain ratings on
both scales, including a considerable amount of high
scores, and the overwhelmingly favorable acceptance of
the faces scale, it seems that these concerns, while still
possibly valid, were not the determining factors in our
sample. Through the detailed process of cognitive inter-
viewing, Kenyan patients demonstrated understanding
and acceptance of both pain scales.
Participants both objectively and subjectively had more
difficulties with the NRS than the FPS-R. Our finding of
the effectively unanimous preference for the faces scale
runs counter to the results of previous studies that have
found that older children and adolescents generally prefer
a numerical scale or a visual analogue scale to the faces
scale [26]. In our study, children and adults across all age
ranges preferred the FPS-R. This may be attributable to
lower levels of education and difficulties with numeracy.
In 2006, Kenya’s adult literacy rate was 61.5%, and its adult
numeracy rate was 64.5% [40]. This may have implications
for pain scales chosen for use in other populations with
low educational levels. Alternatively, our findings may also
be due to a cultural preference among this patient popula-
tion. The subjects raised several questions about the NRS
and had more difficulty correctly identifying the number
that denotes “no pain,” suggesting that the NRS may be a
more problematic scale for use in this population than the
FPS-R.
These findings may serve to caution the recent movement
towards an international standard for pain assessment in
palliative care [21,41]. Based on systematic literature reviews
and expert opinion surveys, the NRS has emerged as the
lead candidate for universal adoption [21]. While we agree
that establishing a universal standard for pain intensitymeasurement is desirable, it may not be feasible to dictate
the use of a single tool that is optimized for all populations.
In concert with other studies in non-Caucasian patient
groups that have found a preference for the FPS-R, our
results serve as a reminder that any efforts to establish a
consensus must include representation from non-Western
populations [42,43].
Despite the concerns encountered during the cognitive
interviewing process, the NRS still has strong potential for
clinical use in our population. All the participants were
able to choose a response to the NRS, and the FPS-R and
NRS ratings were largely consistent subject-by-subject.
Previous studies have reported the many advantages of the
NRS, including ease of administration, straightforward
scoring mechanism, patient preference, and ability to be
used in parametric analyses [15,21,44,45]. The NRS and
FPS-R have different strengths, and these distinctions can
help direct their use in this population in the future. For
example, the FPS-R may be more suitable for day-to-day
patient care, since subjects preferred this scale and found
it easier to understand. On the other hand, the NRS may
be more appropriate for research purposes, as it lends it-
self to statistical analysis and is becoming the international
standard, thereby facilitating comparisons to be made with
other populations.
There were some potential limitations to this study.
We performed 15 cognitive interviews, and if we had
conducted more, we may have found more subtle defi-
ciencies in the pain scales. However, experts generally
recommend doing a maximum of 12 to 15 cognitive
interviews before analysis, as subsequent interviews
reach a point of diminishing returns [35]. Additionally,
the cognitive interviewers are all part of the hospital’s
palliative care team and are familiar with the topics of
pain assessment and treatment. While this may have
biased them towards overestimation of pain or may have
led to a preconceived belief that the pain assessment
tools are acceptable and needed, the use of standardized
scripts for the cognitive interviewing process, and the
process of translation and transcription of the interviews
by a non-palliative care team linguist minimizes the in-
fluence of interviewer bias on our results.Conclusions
In this study, we adapted and translated the FPS-R and
NRS for a population of Swahili-speaking patients in
western Kenya, and demonstrated the face validity, ac-
ceptability, and field-readiness of these scales through
cognitive interviewing of hospitalized patients at MTRH.
Dissemination and use of these pain tools in Kenya and
East Africa could result in increased awareness of
patients’ pain and in an appropriate response in relieving
their suffering.
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